LifeAire is proud to have been recognized as an innovator in life science technology by InterPhex and Pharmaceutical Processing. LifeAire was chosen the winner of InterPhex’s Editor’s Choice award, sponsored by Pharmaceutical Processing.
The Editor of Pharmaceutical Processing awards the Editor’s Choice Award, which is based upon her view of the best in exhibiting in Knowledge, Innovation, and Technologies within the pharma and biopharma industries. For 2018, this award was presented to LifeAire Systems.
LifeAire’s patented, multi-staged, in-duct air purification system designed for the needs of cleanroom, living cell culture, and clinical environments, is ideal for the manufacture of pharmaceutical and biotech intermediates and end products requiring highly-controlled production and testing where sensitivity to ambient air is a factor. It involves the comprehensive removal of chemical and biological airborne pathogens and toxic levels of VOCs and viable particulates present in the processing space, not addressed with current GMP and ISO metrics.
Accepting the award is Dr. Kathryn C. Worrilow, founder and CEO of LifeAire Systems.